https://www.selleckchem.com/products/VX-770.html
A substantial number of persons living with HIV (PLWH) in Nigeria do not experience durable viral suppression on first-line antiretroviral therapy (ART). Understanding risk factors for first-line treatment failure informs patient monitoring practices and distribution of limited resources for second-line regimens. We determined predictors of immunologic and virologic failures in a large ART delivery program in Abuja, Nigeria. A retrospective cohort study was conducted at the University of Abuja Teaching Hospital, a tertiary health care fa
Like
Comment
Share
